Research powered investment banking
Home
Research
Companies
Find Alpha
Themes
Top Picks
Premium
Transactions
Events
Redeye
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
sign in
Home
research
Companies
Find Alpha
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Investor Services
Corporate Broking
Certified Adviser
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Community
  • POSTS

Member profile

My Profile expand-item-icon-hover New Post
mr.charles

mr.charles

  • Blog posts

CLS - From Research to Commercialization Part 3. – The page is about to be turned

MC
mr.charles

2019-04-02
0 comments

The Swedish innovator in immunotherapy against cancer is now only a few days away from the largest clinical presentation made thus far by the company. The co-founder together with two research leaders...

Clinical Laserthermia Systems

Clinical Laserthermia Systems - En intervju med..

MC
mr.charles

2019-01-16
0 comments

Han skrev nyligen, "CLS, för bra för att vara sant", han är återfallsentreprenör och en utav initiativtagarna tillika medgrundarna till CLS. Uppfinningsrikedom och teknisk utveckling är en del utav ha...

Clinical Laserthermia Systems

Clinical Laserthermia Systems – This was a cause before it was a company - From Research to Commercialization through Innovation

MC
mr.charles

2018-10-19
0 comments

The company’s unique method imILT will as of November 2018 reach another milestone when clinical follow-up results are reported to the EU Horizon2020, a method which the company estimates will achieve...

Clinical Laserthermia Systems

CLS metod imILT kan stå inför ett sensationellt genombrott

MC
mr.charles

2018-05-28
0 comments

I detta inlägg ställs överlevnadsdata från CLS studier inom lokalt avancerad inoperabel bukspottskörtelcancer (Stage III pankreascancer) mot 37 st kemoterapier och 10 st molekylärt riktade terapier.

Clinical Laserthermia Systems

Clinical Laserthermia Systems - Från forskning till kommersialisering Del. 2

MC
mr.charles

2018-03-23
0 comments

Under 2017 fick medicinteknikbolaget CLS vad som kan betecknas som ett kommersiellt genombrott. Bolaget fick igång sin försäljning på den amerikanska marknaden och därmed kunde bolaget visa ett positi...

Clinical Laserthermia Systems
  • 1
  • 2

Redeye community rules

The Redeye community members are responsible for their content. As a reader, you’re encouraged to critically analyze the content and do your own research. Before posting or commenting, please review our Rules & Guidelines

Top posts last week

  • Bubblan ingen vill spräcka 2021-01-17 labull
  • Framtidens "gröna" supermaterial från Svenska Aerogel - Quartzene! 2021-01-15 eatsleepmakemoneyrepeat
  • Laddstationsgiganten EVBOX kommer till börsen via merger med tickern TPGY 2021-01-06 Ossomaki


Top authors last week

  • LA
    labull  
  • OS
    Ossomaki  
  • eatsleepmakemoneyrepeat's avatar
    eatsleepmakemoneyrepeat  
  • Office
  • Mäster Samuelsgatan 42, 10th floor
  • Box 7141, 103 87
  • Stockholm, Sweden
  • info@redeye.se
  • +46 (0)8 545 013 30
  • Services
  • Home
  • Research
  • Transactions
  • Events
  • Redeye
  • Community
  • Members Home
  • Premium
  • Legal
  • Terms and conditions (Swedish)
  • Terms of membership (Swedish)
  • Terms and conditions - Advisory (Swedish)
  • Terms and conditions - Advisory (English)
  • Integrity Policy (Swedish)
  • Disclaimer (Swedish)
  • Governance
  • Follow
  • Twitter
  • Facebook
  • LinkedIn
  • Redeye
  • At a Glance
  • Our Culture
  • Investor Services
  • Corporate Broking
  • Corporate Finance
  • Newsroom
  • The Team
  • Careers
  • FAQ

© All rights reserved. Redeye AB is authorised and regulated by the Swedish Financial Supervisory Authority, Finansinspektionen. 2021